Meeks, H. D., Burwinkel, B., Hamann, U., Marmé, F., & Brenner, H. (2016). BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers. Journal of the National Cancer Institute, 108(2), . https://doi.org/10.1093/jnci/djv315
Chicago Style (17th ed.) CitationMeeks, Huong D., Barbara Burwinkel, Ute Hamann, Frederik Marmé, and Hermann Brenner. "BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers." Journal of the National Cancer Institute 108, no. 2 (2016). https://doi.org/10.1093/jnci/djv315.
MLA (9th ed.) CitationMeeks, Huong D., et al. "BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers." Journal of the National Cancer Institute, vol. 108, no. 2, 2016, https://doi.org/10.1093/jnci/djv315.